S. Korea Government Builds Plant To Make Bird Flu Vaccines
This article was originally published in PharmAsia News
South Korea says it expects to have online by the end of next year a new plant capable of producing enough doses of a bird-flu vaccine to treat 20 million patients a year. The Health Ministry announced the plans in a report to Parliament on its plans to deal with a spate of outbreaks of avian flu around the country. The report said the manufacturing facility would be located southwest of Seoul. (Click here for more
You may also be interested in...
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Drawing on the company’s Latin name, Viatris – the proposed combination of Mylan and Upjohn – has unveiled a logo and branding “capturing the company’s commitment to access, leadership and partnership.”
Having recently signed a gene therapy collaboration with Sarepta and received a positive opinion from the CHMP for its kidney transplant therapy, Sweden's Hansa has now raised a substantial sum in a "multiple times oversubscribed" placing.